{"entity":{"type":"insider","cik":"0002001571","url":"/insider/0002001571","json_url":"/insider/0002001571.json","name":"Huntsman Carole","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":6,"first":"2024-11-22","last":"2026-03-06","span_basis":"filed_date"},"name_variants":[{"name":"Huntsman Carole","source":"filing","n_filings":6,"first_seen":"2024-11-22","last_seen":"2026-03-06"}],"transactions":[{"id":5872531,"accession":"0001628280-26-015758","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-015758","line_url":"/filing/0001628280-26-015758#line-2","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0002001571","owner_name":"Huntsman Carole","owner_display_name":"Huntsman Carole","owner_url":"/insider/0002001571","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":419.0,"shares_display":"419","price_per_share":431.94,"price_display":"431.94","price_state":"stated","total_value":180982.86,"total_display":"180,982.86","total_whole":"180,983","shares_owned_after":12692.0,"shares_owned_after_display":"12,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-06","filed_date":"2026-03-06","scope":"insider"},{"id":6055577,"accession":"0001628280-26-003482","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-003482","line_url":"/filing/0001628280-26-003482","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0002001571","owner_name":"Huntsman Carole","owner_display_name":"Huntsman Carole","owner_url":"/insider/0002001571","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":910.0,"shares_display":"910","price_per_share":493.77923076923076,"price_display":"493.78","price_state":"stated","total_value":449339.1,"total_display":"449,339.10","total_whole":"449,339","shares_owned_after":9122.0,"shares_owned_after_display":"9,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-26","filed_date":"2026-01-26","scope":"insider","n_lines":2},{"id":4960749,"accession":"0001628280-25-053648","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001628280-25-053648","line_url":"/filing/0001628280-25-053648","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0002001571","owner_name":"Huntsman Carole","owner_display_name":"Huntsman Carole","owner_url":"/insider/0002001571","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1958.0,"shares_display":"1,958","price_per_share":553.1084,"price_display":"553.11","price_state":"stated","total_value":1082986.2472,"total_display":"1,082,986.25","total_whole":"1,082,986","shares_owned_after":11096.0,"shares_owned_after_display":"11,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-21","filed_date":"2025-11-21","scope":"insider","n_lines":11},{"id":4839332,"accession":"0001628280-25-010492","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001628280-25-010492","line_url":"/filing/0001628280-25-010492","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0002001571","owner_name":"Huntsman Carole","owner_display_name":"Huntsman Carole","owner_url":"/insider/0002001571","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1834.0,"shares_display":"1,834","price_per_share":325.9758342420938,"price_display":"325.98","price_state":"stated","total_value":597839.68,"total_display":"597,839.68","total_whole":"597,840","shares_owned_after":8604.0,"shares_owned_after_display":"8,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider","n_lines":9},{"id":4302771,"accession":"0001628280-25-002680","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-002680","line_url":"/filing/0001628280-25-002680#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0002001571","owner_name":"Huntsman Carole","owner_display_name":"Huntsman Carole","owner_url":"/insider/0002001571","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":347.0,"shares_display":"347","price_per_share":335.24,"price_display":"335.24","price_state":"stated","total_value":116328.28,"total_display":"116,328.28","total_whole":"116,328","shares_owned_after":10438.0,"shares_owned_after_display":"10,438","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-24","filed_date":"2025-01-27","scope":"insider"},{"id":2551425,"accession":"0000950170-24-130239","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-130239","line_url":"/filing/0000950170-24-130239#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0002001571","owner_name":"Huntsman Carole","owner_display_name":"Huntsman Carole","owner_url":"/insider/0002001571","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":688.0,"shares_display":"688","price_per_share":316.92,"price_display":"316.92","price_state":"stated","total_value":218040.96,"total_display":"218,040.96","total_whole":"218,041","shares_owned_after":10785.0,"shares_owned_after_display":"10,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-21","filed_date":"2024-11-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001157601","name":"MADRIGAL PHARMACEUTICALS, INC.","url":"/issuer/0001157601","role":"Officer (Chief Commercial Officer)","n_filings":6,"first_seen":"2024-11-22","last_seen":"2026-03-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002001571","retrieved_at":"2026-08-26T11:45:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}